Previous Article | Next Article ![]()
Journal of Clinical Microbiology, March 2009, p. 845-847, Vol. 47, No. 3
0095-1137/09/$08.00+0 doi:10.1128/JCM.01528-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Department of TB Control, Shanghai Municipal Centers for Disease Control and Prevention, Shanghai 200336, China,1 Key Laboratory of Medical Molecular Virology, Institutes of Biomedical Sciences and Institute of Medical Microbiology, Fudan University, Shanghai 200032, China,2 Ustar Biotechnologies (Hangzhou) Co., Ltd., Hangzhou, Zhejiang 310012, China3
Received 8 August 2008/ Returned for modification 1 October 2008/ Accepted 22 December 2008
Cross-priming amplification (CPA) technology for tuberculosis diagnosis from sputum specimens was evaluated. The sensitivity of CPA from smear- and liquid culture-positive specimens was 96.9%, and that from smear-negative and liquid culture-positive specimens was 87.5%. The specificity of CPA in culture-negative specimens was 98.8%.
Published ahead of print on 30 December 2008.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»